GlaxoSmithKline

GlaxoSmithKline plc (GSK) was officially formed in 2000 when Glaxo Wellcome plc and SmithKline Beecham plc merged. With a history dating back to a small apothecary shop in London in 1715 and the inception of Glaxo as a baby milk producer in Bunnythorpe, New Zealand, in 1904, the company has deep historical roots. GSK has its headquarters in Brentford, London, United Kingdom. Operating primarily in three business segments, GSK is a key player in the pharmaceuticals sector focusing on prescriptions for disorders such as respiratory problems, HIV/infectious diseases, oncology, and immunology. As a leading vaccine provider, they distribute vaccines for influenza, hepatitis, HPV, and rotavirus. Their consumer healthcare division provides a range of OTC health products covering oral health, pain relief, respiratory products, and nutritional supplements. GSK's notable pharmaceuticals brands include Advair/Seretide, Augmentin, Tivicay, and Triumeq. In the vaccines category, Infanrix/Pediarix, Boostrix, Rotarix, and Cervarix are some of the principal brands. The consumer healthcare segment boasts brands such as Sensodyne, Polident, Panadol, and Otrivin. GSK's products and services are sold globally, with the United States being one of the largest markets. Other key markets are the United Kingdom, European Union countries, Canada, Australia, Japan, and emerging markets including China and India, showcasing GSK’s extensive reach into diverse healthcare markets around the world. (Powered by AI)